Combination therapy with flutamide and medical (LHRH agonist) or surgical castration in advanced prostate cancer: 7-year clinical experience

This publication has 34 references indexed in Scilit:

• A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
  New England Journal of Medicine, 1989
• Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: Unique importance of extratesticular androgens in men
  The Journal of Steroid Biochemistry and Molecular Biology, 1989
• Important prognostic value of standardized objective criteria of response in stage D2 prostatic carcinoma
  European Journal of Cancer and Clinical Oncology, 1988
• Development of androgen resistance in mouse mammary tumor cells can be prevented by the antiandrogen flutamide
  The Prostate, 1987
• A wide range of sensitivities to androgens develops in cloned shionogi mouse mammary tumor cells
  The Prostate, 1986
• Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer.
  BMJ, 1985
• Control of secretion and the function of C19-Δ5-steroids of the human adrenal gland
  Molecular and Cellular Endocrinology, 1985
• Treatment of advanced prostatic cancer, resistant to conventional therapy with aminoglutethimide
  European Journal of Cancer and Clinical Oncology, 1985
• Leuprolide versus Diethylstilbestrol for Metastatic Prostate Cancer
  New England Journal of Medicine, 1984
• Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer.
  BMJ, 1983